FDA: Does Not Intend to Take Action Against Compounders for Violations of FD&C Act Arising From Conditions That Depend on Tirzepatide Injection
FDA:不打算對因依賴Tirzepatide注射而違反FD&C法的複方藥製劑採取行動。
FDA: Does Not Intend to Take Action Against Compounders for Violations of FD&C Act Arising From Conditions That Depend on Tirzepatide Injection
FDA:不打算對因依賴Tirzepatide注射而違反FD&C法的複方藥製劑採取行動。
使用瀏覽器的分享功能,分享給你的好友吧